Synonyms: Melflufen | Pepaxti® | Pepaxto® | Prodrug J 1 | Prodrug J-1
melphalan flufenamide is an approved drug (FDA (2021), EMA (2022))
Compound class:
Synthetic organic
Comment: Melphalan flufenamide is a peptide-conjugated prodrug of the cytotoxic DNA alkylating drug melphalan [3]. It is highly lipophilic and is rapidly transported into cells where it is quickly hydrolysed by aminopeptidases that are overexpressed by some cancer cells. Melphalan flufenamide is being evaluated as a treatment for multiple myeloma [2,5-6].
The IUPAC Condensed peptide sequence for melphalan flufenamide is H-Phe(Unk)-Phe(4-F)-OEt. |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2021) | EMA (2022) |
Is prodrug? | Yes |
Active form | melphalan |
IUPAC Name ![]() |
ethyl (2S)-2-[[(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoyl]amino]-3-(4-fluorophenyl)propanoate |
International Nonproprietary Names ![]() |
|
INN number | INN |
9493 | melphalan flufenamide |
Synonyms ![]() |
Melflufen | Pepaxti® | Pepaxto® | Prodrug J 1 | Prodrug J-1 |
Database Links ![]() |
|
CAS Registry No. | 380449-51-4 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4303060 |
GtoPdb PubChem SID | 442878639 |
PubChem CID | 9935639 |
Search Google for chemical match using the InChIKey | YQZNKYXGZSVEHI-VXKWHMMOSA-N |
Search Google for chemicals with the same backbone | YQZNKYXGZSVEHI |
Search PubMed clinical trials | melphalan flufenamide |
Search PubMed titles | melphalan flufenamide |
Search PubMed titles/abstracts | melphalan flufenamide |
UniChem Compound Search for chemical match using the InChIKey | YQZNKYXGZSVEHI-VXKWHMMOSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YQZNKYXGZSVEHI-VXKWHMMOSA-N |